Ternary Therapeutics targets “undruggable” proteins with AI-designed molecular glues, raising €4.1 million
Ternary Therapeutics targets “undruggable” proteins with AI-designed molecular glues, raising €4.1 million London-based BioTech startup Ternary Therapeutics has raised €4.1 million (£3.6 million) in Seed funding to scale an AI platform designed to create a new class of medicines known as molecular glues. The round was led by European venture

